In terms of ADAS-Cog scores, the placebo group experienced a significant decline from their initial baseline score, whereas the EGb group showed a trend of improvement.
← all excerpts
<i>Ginkgo biloba</i>: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review.
1
—
—